Printer Friendly
The Free Library
14,503,743 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Web Alert: Advanced Cell Technology Presents Stem Cell Technologies and Programs Today at Rodman & Renshaw Healthcare Conference in New York.


Online Webcast of CEO's Overview of Technology Platforms and Therapeutic Development Initiatives also Available

ALAMEDA, Calif. -- Advanced Cell Technology (ACTC ACTC Apple Certified Technical Coordinator
ACTC Almaden Cycle Touring Club
ACTC Associated Colleges of the Twin Cities
ACTC All Ceylon Tamil Congress (Sri Lanka)
ACTC Association Canadienne de Télévision par Câble
), Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:ACTC), applying proprietary human embryonic stem (ES) cell technology to the emerging field of regenerative re·gen·er·a·tive  
adj.
1. Of, relating to, or marked by regeneration.

2. Tending to regenerate.



re·gen
 medicine, will present an overview of its stem cell-based therapeutic development programs and proprietary technologies today at the Rodman & Renshaw 8th Annual Healthcare Conference in New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
.

A live webcast of the presentation, by Chief Executive Officer William M. Caldwell, IV, will also be accessible online during the presentation and archived for 90 days. Details of the conference presentation and webcast are below.
WHAT:       ACTC Presentation at Rodman & Renshaw 8th Annual
            Healthcare Conference

WHO:        Chief Executive Officer William M. Caldwell, IV

WHEN:       Today, November 6, 2006, at 11:40 a.m. EST.

WHERE:      Kennedy II Room, 4th Floor, Palace Hotel, 455
            Madison Ave., New York, NY

WEBCAST:    An online webcast of the presentation will be accessible
            at www.advancedcell.com.

ARCHIVE:    A downloadable copy of the presentation will also be
            available on the Company's website at
            www.advancedcell.com/conference-presentations/.


In the presentation, Mr. Caldwell will spotlight the company's technologies and programs to develop novel stem cell therapies stem cell therapy Cell therapy Molecular medicine A technology in which a person's own cells–eg, neuronal stem cells are triggered to revert to their primitive embryonic form, then redifferentiate into mature cells of various organs  in the fields of vision, cardiovascular disease Cardiovascular disease
Disease that affects the heart and blood vessels.

Mentioned in: Lipoproteins Test

cardiovascular disease 
 and dermal dermal /der·mal/ (der´mal) pertaining to the dermis or to the skin.

der·mal or der·mic
adj.
Of or relating to the skin or dermis.
 wound repair for scarless healing from burns, surgery and other causes.

The Rodman & Renshaw conference will feature presentations from over 300 companies representing the medical device, pharmaceutical and biotechnology industries.

For more information about the Rodman & Renshaw conference, visit http://www.rodmanandrenshaw.com.

About Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc. is a biotechnology company applying embryonic stem cell Embryonic stem cells (ES cells) are stem cells derived from the inner cell mass of an early stage embryo known as a blastocyst. Human embryos reach the blastocyst stage 4-5 days post fertilization, at which time they consist of 50-150 cells.

ES cells are pluripotent.
 technology in the emerging field of regenerative medicine. The company operates facilities in Alameda, California Alameda is a city in Alameda County, California, United States. It is located on a small island of the same name next to Oakland, California in the San Francisco Bay. An additional part of the city is Bay Farm Island, which is adjacent to the Oakland International Airport.  and Worcester, Mass.

For more information, please visit: www.advancedcell.com. For investor-specific information and resources, visit http://www.trilogy-capital.com/tcp/advanced_cell. To read or download Advanced Cell's Investor Fact Sheet, please visit http://www.trilogy-capital.com/tcp/advanced_cell/factsheet.html. To view recent stock quotes and news, visit http://www.trilogy-capital.com/tcp/advanced_cell/quote.html.

Forward-Looking Statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.


Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates" and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-QSB for the quarter ended June 30, 2006.

Forward-looking statements are based on the beliefs, opinions and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations or other circumstances should change.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 6, 2006
Words:565
Previous Article:The Incredible Hulk to Smash into Theaters June 27, 2008.
Next Article:Doubletree(R) Hotel Historic Savannah Receives Top Accolades from Hilton Hotels Corporation for Excellence in Customer Service.
Topics:



Related Articles
StemCells to Present at Investment and Scientific Conference.
Advanced Cell Technology's Chief Scientific Officer Michael West, Ph.D. to be Featured Guest Speaker at Rodman & Renshaw Techvest 7th Annual...
Advanced Cell Technology to Present Stem Cell Programs at Rodman & Renshaw's Annual Healthcare Conference in New York.
Rodman & Renshaw Healthcare Conference 2006 Additional Presenter Profile.
International Stem Cell Corporation to Present at Rodman & Renshaw 8th Annual Healthcare Conference November 6-8, 2006.
Geron to Present at Rodman & Renshaw 8th Annual Healthcare Conference.
Cytori Therapeutics to Present at the Rodman & Renshaw 8th Annual Healthcare Conference.
Opexa Therapeutics to Present at Rodman & Renshaw Eighth Annual Healthcare Conference.
Rodman & Renshaw Global Healthcare Conference 2007 Presenter Profiles.
Geron Corporation to Present at Rodman & Renshaw Healthcare Conference.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles